Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 25.

Buadze, Anna; Kaiser, S; Stohler, R; Roessler, W; Seifritz, E; Fusar-Poli, P; Liebrenz, M (2012). Patient's perceptions of the cannabis-psychosis link--a systematic review. Current Pharmaceutical Design, 18:5105-5112.

Herdener, M; Oppliger, R; Stohler, R; Caflisch, C (2012). Behandlung der Kokainabhängigkeit. Praxis, 101(16):1013-1019.

Reissner, V; Kokkevi, A; Schifano, F; Room, R; Storbjörk, J; Stohler, R; DiFuria, L; Rehm, Jürgen; Geyer, M; Hölscher, F; Scherbaum, N (2012). Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). European Psychiatry, 27(6):455-462.

Hess, M; Boesch, L; Leisinger, R; Stohler, R (2011). Transdermal Buprenorphine to Switch Patients from Higher Dose Methadone to Buprenorphine without Severe Withdrawal Symptoms. American Journal on Addictions, 20(5):480-481.

Nordt, C; Stohler, R (2010). Combined effects of law enforcement and substitution treatment on heroin mortality. Drug and Alcohol Review, 29(5):540-545.

Strasser, J; Wiesbeck, G A; Meier, N; Stohler, R; Dürsteler-MacFarland, K M (2010). Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients. Journal of Clinical Psychopharmacology, 30(4):450-454.

Liebrenz, M; Stohler, R; Caflisch, C (2010). Abhängigkeitssyndrom von Benzodiazepinen, gegenwärtige Teilnahme an einem ärztlich überwachten Ersatz(drogen)-programm (ICD-10 F13.22) – Evidenzen und eigene Ergebnisse. Suchttherapie, 11(3):112-115.

Liebrenz, M; Boesch, L; Stohler, R; Caflisch, C (2010). Agonist substitution - a treatment alternative for high-dose benzodiazepine-dependent patients? Addiction, 105(11):1870-1874.

Kläusler, B; Stohler, R (2010). Buchrezension: Küfner, H. & Ridinger, M. (2008). Psychosoziale Behandlung von Drogenabhängigen unter Substitution (PSB-D). Lengerich: Dustri Pabst Science Publishers. Sucht, 56(1):77-78.

Nordt, C; Stohler, R (2010). Der Heroinmarkt in Zürich. SuchtMagazin, (6):37-38.

Hölscher, F; Reissner, V; Di Furia, L; Room, R; Schifano, F; Stohler, R; Yotsidi, V; Scherbaum, N (2010). Differences between men and women in the course of opiate dependence: is there a telescoping effect. European Archives of Psychiatry and Clinical Neuroscience, 260(3):235-241.

Buadze, A; Stohler, R; Schulze, B; Liebrenz, M (2010). Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia. Harm Reduction Journal, 7:22.

Stohler, R (2010). Moderater Gebrauch von Cannabis. Suchttherapie, 11(1):29-30.

Falcato, L; Stohler, R; Schaub, Michael P (2010). Moderater Substanz-Gebrauch: Konzeptioneller Rahmen für ein neues Paradigma? Suchttherapie, 11(1):9-13.

Wiesbeck, G; Stohler, R (2009). Alkohol-bezogene Störungen. In: Gerlach, M; Warnke, A; Wewetzer, C. Neuro-Psychopharmaka im Kindes- und Jugendalter. Grundlagen und Therapie. Wien: Springer, 345-352.

Stohler, R; Wiesbeck, G (2009). Drogen-(Substanz-)bezogene Störungen. In: Gerlach, M; Warnke, A; Wewetzer, C. Neuro-Psychopharmaka im Kindes- und Jugendalter. Grundlagen und Therapie. Wien: Springer, 405-414.

Liebrenz, M; Stohler, R; Caflisch, C (2009). Benzodiazepin-Abhängigkeit und ihre Behandlungsmöglichkeiten. SuchtMagazin, 14(6):20-23.

Nordt, C; Landolt, K; Stohler, R (2009). Estimating incidence trends in regular heroin use in 26 regions of Switzerland using methadone treatment data. Substance Abuse Treatment, Prevention, and Policy, 4:14.

Nordt, C; Stohler, R (2009). Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: the Zurich experience. International Journal of Drug Policy, 20(6):497-501.

Liebrenz, M; Stohler, R; Borgeat, A (2009). Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression. World Journal of Biological Psychiatry, 10(4 Pt 2):640-643.

Nordt, C; Stohler, R (2008). Estimating heroin epidemics with data of patients in methadone maintenance treatment, collected during a single treatment day. Addiction, 103(4):591-597.

Gabriel, T; Stohler, R (2008). Transitions to adulthood of young care leavers in Switzerland. In: Steiner, M. Young People's Transitions from Care to Adulthood: International Research and Practice. London: Jessica Kingsley Publishers, 197-208.

Dursteler-Mac Farland, K; Stohler, R; Modovanyi, A; Rey, S; Basdekis, R; Gschwend, P; Eschmann, S; Rehm, Jürgen (2006). Complaints of heroin-maintained patients: a survey of symptoms ascribed to diacetylmorphine. Drug and Alcohol Dependence, 81(3):231-239.

Eich, D; Figner, B (2005). Having attention-deficit/hyperactivity disorder and substance use disorder: a review of the literature. In: Stohler, R; Rössler, W. Dual Diagnosis. The Evolving Conceptual Framework. Basel: Karger, 92-104.

Stoermer, R; Drewe, J; Dursteler-Mac Farland, K M; Hock, C; Mueller-Spahn, F; Ladewig, D; Stohler, R; Mager, R (2003). Safety of injectable opioid maintenance treatment for heroin dependence. Biological Psychiatry, 54(8):854-861.

This list was generated on Sat Nov 18 11:31:27 2017 CET.